A new vaccine is offering hope for people fighting an aggressive form of breast cancer. Dr. Michael Daignault talks about ...

A new therapeutic vaccine offers fresh hope for women battling super aggressive triple-negative cancer. The vaccine teaches ...

A breast cancer vaccine could be closer to reality, according to Cleveland Clinic, as its researchers have announced some ...

Shares of vaccine makers closed lower Thursday amid reports that President-elect Donald Trump was set to nominate vaccine ...

Analysts have set 12-month price targets for BioNTech, revealing an average target of $132.24, a high estimate of $171.00, ...

A small clinical trial shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to prevent recurrence of tumors.

BioNTech, the German developer of a widely used mRNA vaccine for the coronavirus, agreed to pay US$800 million (HK$6.24 billion) to buy biotech company Biotheus, a developer of cancer drugs. In a ...

University of Zagreb researcher Beata Halassy treated her breast cancer with an unproven virus-based therapy using viruses ...

BioNTech is investing in a promising space in oncology by acquiring Biotheus’ PD-L1 and VEGF bispecific antibody.

The acquisition was part of BioNTech's broader oncology strategy, backed by the financial success of its Covid-19 vaccine ...

BioNTech said that BNT327 has the "potential to replace current checkpoint inhibitor standard of care treatments for solid ...